Back to Journals » Vascular Health and Risk Management » Volume 3 » Issue 1

Management of atrial fibrillation

Authors Puneet Kakar, Christopher J Boos, Gregory YH Lip

Published 15 March 2007 Volume 2007:3(1) Pages 109—116



Puneet Kakar1, Christopher J Boos1,2, Gregory YH Lip1

1Hemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK; 2Army Medical Directorate, FASC, Camberley, Surrey, UK

Abstract: Atrial fibrillation (AF) is a condition of genuine clinical concern. This arrhythmia increases patient morbidity and mortality, most notably due to stroke, thromboembolism and heart failure. Consequentially, there is a strong impetus to acquire a greater understanding of its natural history and course in order to provide crucial evidence-based treatment and resource allocation in the future. The objective of this review article is to present a concise overview of the management of AF, with reference to the recent evidence-based National Institute of Clinical Excellence (NICE) National Clinical Guidelines for the management of AF.

Keywords: atrial fibrillation, National Institute of Clinical Excellence, guidelines